Alioth
Shanghai
About Alioth
Elios focusing on the development and application of pharmaceutical process technology and related products. The company is dedicated to providing high-quality separation and purification solutions that comply with domestic and international regulations to pharmaceutical companies. In order to meet GMP requirements, Elios established its own production bases in Lingang, Shanghai, and Hangzhou. It has process development labs, verification labs, and filtration product R&D centers, as well as a research and development team led by membrane technology scientists to better safeguard supply chain security.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 51 – 100
- Total funding: $54.7M
- Funding stage: Early Stage Venture
- Last round: Series B (Jan 2026)
- Website: aliothbio.com
- Phone: 400-626-3749
Industries & Categories
Biopharma, Biotechnology, Health Care, Medical, Pharmaceutical
Social Profiles
Canonical: https://fsome.com/organization/alioth-60409 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.